Transactions under Novonesis’ share buyback program

As of June 20th, 2025, Novonesis has purchased an accumulated 1,660,344 shares with a transaction value of DKK 713,0 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025. Under the program, Novonesis will buy back B shares worth up to EUR 100 million (DKK 746 million) in total during the remainder of 2025.

Please read the full announcement in PDF 

Attachment

• 2025_34_Share_buyback_program

You May Also Be Interested In

• New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program
• Nouryon brings U.S. solar project online at Morris, Illinois, facility
• Carbon Streaming Sells 100% of the Community Carbon Stream and Inventory of Carbon Credits for US$6,000,000